Elite Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
5.10-305.8633.00-21.67-8.77-26.0011.113.960.007.724.14-8.77
Price/Sales ratio
29.4716.7113.0510.6710.753.232.221.090.002.740.903.23
Price/Book Value ratio
-4.2518.714.904.307.145.463.501.401.012.690.995.46
Price/Cash Flow ratio
-9.78-75.54-15.95-16.55-11.98-32.4717.715.428.79-47.3410.26-11.98
Price/Free Cash Flow ratio
-8.64-44.31-13.99-15.65-11.95-31.8519.755.87-12.24-37.97-3.85-11.95
Price/Earnings Growth ratio
-0.042.99-0.010.18-0.050.34-0.030.06N/A-0.070.04-0.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
39.91%64.12%38.79%52.92%37.88%44.33%46.75%45.85%48.58%46.54%48.69%37.88%
Operating Profit Margin
-329.13%-66.54%-76.32%-121.35%-121.01%-12.70%8.29%15.71%5.92%19.05%14.81%-121.01%
Pretax Profit Margin
576.76%-9.62%20.16%-63.26%-131.53%-12.43%16.32%19.54%11.66%0.81%16.66%-131.53%
Net Profit Margin
576.83%-5.46%39.54%-49.24%-122.60%-12.45%20.04%27.58%12.91%35.51%21.75%-122.60%
Effective Tax Rate
-0.01%43.24%-83.83%15.05%4.29%-0.08%-22.77%-27.54%-10.63%-4242.25%-30.55%-0.08%
Return on Assets
111.61%-2.14%11.10%-11.89%-38.02%-8.97%19.42%25.31%10783.20%24.03%13.69%-38.02%
Return On Equity
-83.29%-6.11%14.85%-19.88%-81.42%-21.02%31.50%35.27%15227.42%34.92%26.71%-81.42%
Return on Capital Employed
-79.16%-30.54%-23.75%-35.12%-52.34%-14.00%10.32%17.82%6125.12%15.28%10.66%-52.34%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.98N/A
Quick Ratio
1.832.883.581.720.620.701.231.811.522.073.520.62
Cash ratio
1.472.473.161.400.320.130.541.270.990.542.690.32
Days of Sales Outstanding
105.2644.6935.3733.0763.7483.3050.2834.590.03125.3961.0083.30
Days of Inventory outstanding
367.22268.10397.02509.17350.61150.96135.39140.860.19155.92184.42184.42
Operating Cycle
472.49312.79432.40542.24414.36234.26185.67175.460.23281.32199.46234.26
Days of Payables Outstanding
409.80146.8764.96172.37106.7857.5025.1129.900.0532.7331.5657.50
Cash Conversion Cycle
62.69165.91367.43369.87307.57176.76160.56145.560.18248.5874.91176.76
Debt Ratios
Debt Ratio
0.140.100.070.120.160.140.080.040.090.090.420.16
Debt Equity Ratio
-0.100.300.100.210.340.340.130.060.130.130.740.34
Long-term Debt to Capitalization
-0.080.160.070.150.220.140.090.050.100.05N/A0.14
Total Debt to Capitalization
-0.110.230.090.170.250.250.110.060.110.11N/A0.25
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.79N/A
Cash Flow to Debt Ratio
-4.10-0.80-2.97-1.20-1.70-0.491.483.730.86-0.43N/A-1.70
Company Equity Multiplier
-0.742.851.331.672.142.341.621.391.411.451.742.34
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.01-0.22-0.81-0.64-0.89-0.090.120.200.00-0.050.08-0.89
Free Cash Flow / Operating Cash Flow Ratio
1.131.701.141.051.001.010.890.92-0.711.24-2.661.01
Cash Flow Coverage Ratio
-4.10-0.80-2.97-1.20-1.70-0.491.483.730.86-0.43N/A-1.70
Short Term Coverage Ratio
-14.27-2.18-16.18-7.34-10.38-0.967.7718.3910.74-0.76137.74-10.38
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A